It is still only a letter of intent and not a firm agreement. On July 21, the German laboratory BioNTech and its American partner Pfizer signed with the South African Biovac for a possible production in Africa of their message RNA vaccine (mRNA) against the Covid-19, the Comirnaty, with the aim of distribution on the African continent. The project involves Biovac’s production facilities in Cape Town, South Africa. The South African laboratory would be supplied with active principle from the productions of Pfizer / BioNtech and their subcontractors in Europe. And Biovac would be in charge of the second stage of vaccine production, which includes formulation, filling and packaging.
Source: UsineNouvelle – Actualités A la une by www.usinenouvelle.com.
*The article has been translated based on the content of UsineNouvelle – Actualités A la une by www.usinenouvelle.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!